Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
18-Dec-2019
Change of Registered Office and Principal Place of Business
17-Dec-2019
Shareholder Update / 2019 Review
29-Nov-2019
App 4D - Financial Report Half Year Ended 30 Sep 2019
1-Nov-2019
App 4C - Sep 2019 Qtr Cash Flows Statement
17-Sep-2019
Change of Director's Interest - Dr Robert Peach - Placement
17-Sep-2019
Change of Director's Interest - Dr C Behrenbruch - Placement
17-Sep-2019
Change of Director's Interest - Dr Warwick Tong, Placement
17-Sep-2019
Placement Cleansing Notice
17-Sep-2019
App 3B Placement Shares and Options to Directors and Mgt
2-Sep-2019
Amplia Therapeutics Provides Manufacturing Update
1
2
3
4
Next
